Management of undifferentiated (anaplastic) thyroid cancer Book Section
| Authors: | Marcadis, A. R.; Shaha, A. R. |
| Article/Chapter Title: | Management of undifferentiated (anaplastic) thyroid cancer |
| Abstract: | Undifferentiated (anaplastic) thyroid cancer (ATC) is the rarest yet most aggressive thyroid cancer. Most patients present with a rapidly enlarging thyroid mass, and the majority die within 6 months of diagnosis. ATC commonly occurs from dedifferentiation of a previously well-differentiated thyroid cancer, though it may arise de novo in some cases. Optimal management of ATC involves a multidisciplinary approach with a combination of surgery, radiotherapy, chemotherapy, and most recently, immunotherapy, to provide the best quality of life with the longest survival. Despite advances in ATC management, there is still much work ahead to improve survival for this lethal disease. © 2020 Elsevier Inc. All rights reserved. |
| Keywords: | thyroidectomy; anaplastic thyroid cancer; undifferentiated thyroid cancer; atc |
| Book Title: | Advances in Treatment and Management in Surgical Endocrinology |
| ISBN: | 9780323661959 |
| Publisher: | Elsevier Inc. |
| Publication Place: | St. Louis, MO |
| Date Published: | 2020-01-01 |
| Start Page: | 27 |
| End Page: | 34 |
| Language: | English |
| DOI: | 10.1016/b978-0-323-66195-9.00003-0 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book Chapter: 3 -- Export Date: 1 December 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work